OK but
(1) what about the fact that to a large extent they’re not actually talking about saving lives if you look into the details of the cost-effectiveness estimate?
(2) GiveWell’s analysis does not account for the kind of publication bias end users of GiveWell’s recommendations should expect, so yes this does analytically imply that we should adjust the $5k substantially downwards based on some kind of model of what kinds of effectiveness claims get promoted to our attention.
OK but (1) what about the fact that to a large extent they’re not actually talking about saving lives if you look into the details of the cost-effectiveness estimate? (2) GiveWell’s analysis does not account for the kind of publication bias end users of GiveWell’s recommendations should expect, so yes this does analytically imply that we should adjust the $5k substantially downwards based on some kind of model of what kinds of effectiveness claims get promoted to our attention.